acquired
Stage
5
Investors
About
V-Wave develops a percutaneous implantable interatrial shunt device designed to reduce elevated left atrial pressure by shunting blood from the left atrium to the right atrium, targeting treatment of patients with chronic heart failure.
Explore V-Wave's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.